DARE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Dare Bioscience Inc (DARE) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock exhibits a bearish technical trend, poor financial performance, no positive news or catalysts, and lacks trading signals from Intellectia Proprietary Trading Signals. Additionally, there is no evidence of insider or influential trading activity to suggest confidence in the stock.
The stock is in a bearish trend with MACD below zero and negatively expanding, RSI at 11.739 indicating oversold conditions, and moving averages showing a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support levels (S1: 1.318, S2: 1.245), with no signs of reversal.
NULL. No recent news, no positive trading trends, and no influential trading activity.
The stock price dropped 7.14% in the regular market session, and the financial performance in Q3 2025 shows significant declines in revenue (-94.57% YoY), net income (-24.24% YoY), and EPS (-49.09% YoY). Technical indicators are bearish, and there is no recent news or positive sentiment.
In Q3 2025, the company reported a revenue drop of -94.57% YoY to 2262, a net income drop of -24.24% YoY to -3562766, and an EPS decline of -49.09% YoY to -0.28. Gross margin remained flat at 100%. Overall, the financial performance is weak and shows no signs of growth.
No recent analyst ratings or price target changes are available.
